Cargando…
The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy
Breast cancer (BC) is the most common tumor in women, and the molecular mechanism underlying its pathogenesis remains unclear. In this study, we aimed to investigate gene modules related to the phenotypes of BC, and identify representative candidate biomarkers for clinical prognosis of BC patients....
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787223/ https://www.ncbi.nlm.nih.gov/pubmed/35087836 http://dx.doi.org/10.3389/fcell.2021.798221 |